P-0143
Québec, Québec
Canada G1J 1Z4
Dernières nouvelles
Information non disponible
- Blanchet, ManonEmployéHôpital de l'Enfant-Jésus+1 418-649-0252, poste 63530manon.blanchet@crchudequebec.ulaval.ca
1401 18e Rue
Recherche neuromusculaire
P-0140
Québec, QC
Canada G1J 1Z4 - Simard, AlexandraEmployéHôpital de l'Enfant-Jésus+1 418-649-0252, poste 63559Alexandra.Simard@crchudequebec.ulaval.ca
1401, 18e Rue
Recherche neuromusculaire
P-0145
Québec, Québec
Canada G1J 1Z4
SF2Former: Amyotrophic lateral sclerosis identification from multi-center MRI data using spatial and frequency fusion transformer
Article de revueComput Med Imaging Graph, 108 , 2023.
Speech timing and monosyllabic diadochokinesis measures in the assessment of amyotrophic lateral sclerosis in Canadian French
Article de revueInt J Speech Lang Pathol, 2023.
Efficacy and safety of iscalimab, a novel anti-CD40 monoclonal antibody, in moderate-to-severe myasthenia gravis: A phase 2 randomized study
Article de revueJ Clin Neurosci, 119 , 2023.
CAPTURE ALS: the comprehensive analysis platform to understand, remedy and eliminate ALS
Article de revueAmyotroph Lateral Scler Frontotemporal Degener, 24 (1-2), 2023.
Genetic testing for amyotrophic lateral sclerosis in Canada - an assessment of current practices
Article de revueAmyotroph Lateral Scler Frontotemporal Degener, 23 (3-4), 2022.
Distinct patterns of progressive gray and white matter degeneration in amyotrophic lateral sclerosis
Article de revueHum Brain Mapp, 43 (5), 2022.
Defining cognitive impairment in amyotrophic lateral sclerosis: an evaluation of empirical approaches
Article de revueAmyotroph Lateral Scler Frontotemporal Degener, 23 (7-8), 2022.
Functional alterations in large-scale resting-state networks of amyotrophic lateral sclerosis: A multi-site study across Canada and the United States
Article de revuePLoS One, 17 (6), 2022.
Rate of speech decline in individuals with amyotrophic lateral sclerosis
Article de revueSci Rep, 12 (1), 2022.
A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of Reldesemtiv In Patients With ALS
Article de revueAmyotroph Lateral Scler Frontotemporal Degener, 22 (3-4), 2021.
Projets actifs
- Élaboration d'une base de données pour la clinique des maladies neuromusculaires du CHU de Québec , du 2022-04-01 au 2026-03-31